Norethindrone Acetate And Ethinyl Estradiol Kit
Product Images NDC 0378-7283

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Norethindrone Acetate And Ethinyl Estradiol (NDC 0378-7283). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Mylan Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Graph (6ba530ce 2499 4963 850e 620b8956af7b 02)

FDA Label Image

Blister Image With Instructions (6ba530ce 2499 4963 850e 620b8956af7b 03)

Blister Image With Instructions (6ba530ce 2499 4963 850e 620b8956af7b 03)
This text provides instructions to start taking birth control pills. It includes guidelines for both Sunday and Day-1 starters and instructions for placing the day label strip. The text also mentions the name, dosage, and storage temperature of the birth control pills. It advises taking the pills from left to right each week.*
FDA Label Image

Day Label Sticker (6ba530ce 2499 4963 850e 620b8956af7b 04)

Day Label Sticker (6ba530ce 2499 4963 850e 620b8956af7b 04)
This text appears to be a set of instructions for using a period tracker. It instructs the user to select the day label strip that corresponds with the start of their period and place it over a pre-printed area with the days of the week. The text includes abbreviations for the days of the week, and mentions skipping steps if the first day of the period falls on a Sunday.*
FDA Label Image

Blister Image With Instructions (6ba530ce 2499 4963 850e 620b8956af7b 05)

Blister Image With Instructions (6ba530ce 2499 4963 850e 620b8956af7b 05)
This is a set of instructions for people on oral contraceptive medication. The text provides guidance on how to begin the medication pack, depending on the start date of the menstrual cycle. The medication is described as Norethindrone Acetate and EthinylEstradiol Tablots USP, 1 mg/0.02 mg and Forrous Fumarato Tablots. The user is instructed to take the pills from left to right each week and store them at room temperature.*
FDA Label Image

Day Sticker Label (6ba530ce 2499 4963 850e 620b8956af7b 06)

Day Sticker Label (6ba530ce 2499 4963 850e 620b8956af7b 06)
This text appears to be a set of instructions for using a menstrual cycle tracking tool. It provides guidance on how to select and apply a day label strip to mark the start of a menstrual cycle on a preprinted calendar that displays the days of the week. The text also notes that if the first day of a menstrual period starts on a Sunday, the aforementioned step can be skipped.*
FDA Label Image

Image 01

Image 01
Norethindrone Acetate and Ethinyl Estradiol Tablets, USP and Ferrous Fumarate Tablets are intended for use as oral contraceptives to prevent pregnancy. The product contains 21 tablets in a pack, with each tablet containing 1mg norathindrone acetaa and 0.02mg etinyl asradiol. The pack also includes 4 brown tablets. This product does not protect against sexually transmitted diseases, including AIDS. The Patient Instructions included in each pouch provide instructions to the patient. Store at 20°-25°C (68"-77°F) and keep out of the reach of children.*
FDA Label Image

Image 02

Image 02
Norethindrone Acetate is a medication used for birth control and hormonal disorders. It is a type of progestin hormone that works by preventing ovulation and altering the cervical mucus to make it harder for sperm to reach the egg. Norethindrone Acetate is available in various forms, including pills, injections, and implants. It is important to take this medication as prescribed to ensure effectiveness and prevent any potential side effects.*
FDA Label Image

Image 03

Image 03
This text provides a list of studies with their respective effect estimates, comparing Ever COC (combined oral contraceptive pill) users versus Never COC users, as well as the effect estimate of Current COC use versus Never-use. The studies include the NICHD Women's Care Study, French E3N cohort Study, Shanghai Women's Health Study, The Nurses' Health Study II, and the Oxford Family Planning Study. The effect estimate is presented as OR, RR, or HR values along with their corresponding confidence intervals. It is unclear what the studies were investigating.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.